NumerixS Investment Technologies Inc acquired a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) in the fourth quarter, Holdings Channel reports. The fund acquired 1,800 shares of the company’s stock, valued at approximately $108,000.
Several other hedge funds have also modified their holdings of NUS. Advisors Asset Management Inc. raised its position in shares of Nu Skin Enterprises by 16.0% during the 4th quarter. Advisors Asset Management Inc. now owns 2,720 shares of the company’s stock valued at $167,000 after buying an additional 375 shares in the last quarter. Ffcm LLC raised its position in shares of Nu Skin Enterprises by 181.9% during the 3rd quarter. Ffcm LLC now owns 1,911 shares of the company’s stock valued at $177,000 after buying an additional 1,233 shares in the last quarter. Ibex Investors LLC purchased a new stake in shares of Nu Skin Enterprises during the 3rd quarter valued at about $201,000. Engineers Gate Manager LP purchased a new stake in shares of Nu Skin Enterprises during the 3rd quarter valued at about $204,000. Finally, NINE MASTS CAPITAL Ltd purchased a new stake in shares of Nu Skin Enterprises during the 3rd quarter valued at about $206,000. 74.29% of the stock is owned by hedge funds and other institutional investors.
Shares of NYSE:NUS opened at $59.00 on Friday. The stock has a market cap of $3.28 billion, a P/E ratio of 16.76, a PEG ratio of 1.39 and a beta of 0.68. Nu Skin Enterprises, Inc. has a 12 month low of $56.09 and a 12 month high of $88.68. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.15 and a current ratio of 1.82.
Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Wednesday, February 13th. The company reported $1.05 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.05. The business had revenue of $683.29 million for the quarter, compared to the consensus estimate of $676.76 million. Nu Skin Enterprises had a net margin of 4.55% and a return on equity of 25.98%. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.20 EPS. On average, equities analysts forecast that Nu Skin Enterprises, Inc. will post 3.91 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 13th. Shareholders of record on Monday, February 25th were paid a $0.37 dividend. This is an increase from Nu Skin Enterprises’s previous quarterly dividend of $0.37. This represents a $1.48 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend was Friday, February 22nd. Nu Skin Enterprises’s dividend payout ratio is currently 42.05%.
NUS has been the topic of several recent research reports. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Thursday, December 20th. Bank of America set a $65.00 target price on shares of Nu Skin Enterprises and gave the company a “sell” rating in a research report on Friday, March 1st. Pivotal Research restated a “buy” rating and set a $85.00 target price on shares of Nu Skin Enterprises in a research report on Wednesday. ValuEngine cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Friday, February 8th. Finally, Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a report on Wednesday, November 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. Nu Skin Enterprises has a consensus rating of “Buy” and an average price target of $80.25.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 1,250 shares of the company’s stock in a transaction dated Wednesday, January 2nd. The shares were sold at an average price of $60.60, for a total value of $75,750.00. Following the transaction, the general counsel now directly owns 32,621 shares in the company, valued at approximately $1,976,832.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.00% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: “1,800 Shares in Nu Skin Enterprises, Inc. (NUS) Purchased by NumerixS Investment Technologies Inc” was published by Stock Observer and is owned by of Stock Observer. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.thestockobserver.com/2019/03/15/1800-shares-in-nu-skin-enterprises-inc-nus-purchased-by-numerixs-investment-technologies-inc.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.